{"id":"https://openalex.org/W2911656649","doi":"https://doi.org/10.1182/blood-2018-99-119949","title":"Acquired Resistance to BRAF Inhibition in Hcl Is Rare and Retreatment with Vemurafenib at Relapse Can Induce High Response Rates: Final Results of a Phase II Trial of Vemurafenib in Relapsed Hcl","display_name":"Acquired Resistance to BRAF Inhibition in Hcl Is Rare and Retreatment with Vemurafenib at Relapse Can Induce High Response Rates: Final Results of a Phase II Trial of Vemurafenib in Relapsed Hcl","publication_year":2018,"publication_date":"2018-11-29","ids":{"openalex":"https://openalex.org/W2911656649","doi":"https://doi.org/10.1182/blood-2018-99-119949","mag":"2911656649"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2018-99-119949","doi":"https://doi.org/10.1182/blood-2018-99-119949","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-119949","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101838284","display_name":"Jae H. Park","orcid":"https://orcid.org/0000-0002-2903-5130","observed_orcids":["https://orcid.org/0000-0002-2903-5130","https://orcid.org/0009-0003-2678-9513"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jae H. Park","raw_affiliation_strings":["Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Ctr., New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Ctr., New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091065629","display_name":"Jeong\u2010Ok Lee","orcid":"https://orcid.org/0000-0001-9402-6372","observed_orcids":["https://orcid.org/0000-0001-9402-6372"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeong-Ok Lee","raw_affiliation_strings":["Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071023119","display_name":"Richard Maury Stone","orcid":"https://orcid.org/0000-0002-7526-2633","observed_orcids":["https://orcid.org/0000-0002-7526-2633"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard M. Stone","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075536647","display_name":"Alan Saven","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103888","display_name":"Scripps Green Hospital","ror":"https://ror.org/01hv74g78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1311914864","https://openalex.org/I4210103888"]},{"id":"https://openalex.org/I4210146328","display_name":"Scripps Clinic","ror":"https://ror.org/05kwjwj05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1311914864","https://openalex.org/I4210146328"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Saven","raw_affiliation_strings":["Scripps Clinic/Scripps Green Hospital, La Jolla, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Scripps Clinic/Scripps Green Hospital, La Jolla, CA","institution_ids":["https://openalex.org/I4210103888","https://openalex.org/I4210146328"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025780450","display_name":"Jessica Kaplan Altman","orcid":"https://orcid.org/0000-0003-1987-1896","observed_orcids":["https://orcid.org/0000-0003-1987-1896"]},"institutions":[{"id":"https://openalex.org/I4390039227","display_name":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University","ror":"https://ror.org/02p4far57","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210147348","https://openalex.org/I4390039227"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica K. Altman","raw_affiliation_strings":["Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL","institution_ids":["https://openalex.org/I4390039227"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051619378","display_name":"Michael R. Grever","orcid":"https://orcid.org/0000-0002-1605-7875","observed_orcids":["https://orcid.org/0000-0002-1605-7875"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael R. Grever","raw_affiliation_strings":["Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Medicine, The Ohio State University, Columbus, OH","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kanti R Rai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1302444339","display_name":"Northwell Health","ror":"https://ror.org/02bxt4m23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339"]},{"id":"https://openalex.org/I1327576362","display_name":"Feinstein Institute for Medical Research","ror":"https://ror.org/05dnene97","country_code":"US","type":"facility","lineage":["https://openalex.org/I1302444339","https://openalex.org/I1327576362"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kanti R Rai","raw_affiliation_strings":["The Feinstein Institute for Medical Research, NorthWell Health System, Manhasset, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Feinstein Institute for Medical Research, NorthWell Health System, Manhasset, NY","institution_ids":["https://openalex.org/I1302444339","https://openalex.org/I1327576362"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086407321","display_name":"Shreya Vemuri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Shreya Vemuri","raw_affiliation_strings":["Sloan Kettering Institute, 1275 York Avenue, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sloan Kettering Institute, 1275 York Avenue, NY","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025595346","display_name":"Omar Ibrahim Abdel-Wahab","orcid":"https://orcid.org/0000-0002-3907-6171","observed_orcids":["https://orcid.org/0000-0002-3907-6171"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Omar I Abdel-Wahab","raw_affiliation_strings":["Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001124933","display_name":"Martin S. Tallman","orcid":"https://orcid.org/0000-0002-4367-6102","observed_orcids":["https://orcid.org/0000-0002-4367-6102"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martin S. Tallman","raw_affiliation_strings":["Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5086407321"],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"132","issue":"Supplement 1","first_page":"392","last_page":"392"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hairy-cell-leukemia","display_name":"hairy cell leukemia","score":0.843999981880188},{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":0.9940000176429749},{"id":"https://openalex.org/keywords/braf-inhibition","display_name":"BRAF inhibition","score":0.8190000057220459},{"id":"https://openalex.org/keywords/relapsed-refractory-disease","display_name":"relapsed/refractory disease","score":0.8209999799728394},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5600000023841858},{"id":"https://openalex.org/keywords/retreatment","display_name":"retreatment","score":0.7749999761581421},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8169999718666077},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.7360000014305115},{"id":"https://openalex.org/keywords/duration-of-response","display_name":"duration of response","score":0.7229999899864197},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.35100001096725464}],"concepts":[{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.9123098850250244},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8688960075378418},{"id":"https://openalex.org/C2780366003","wikidata":"https://www.wikidata.org/wiki/Q246147","display_name":"Cytopenia","level":3,"score":0.8403420448303223},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6212483048439026},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.552621066570282},{"id":"https://openalex.org/C2778551932","wikidata":"https://www.wikidata.org/wiki/Q285115","display_name":"Organomegaly","level":3,"score":0.5076388120651245},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.46370014548301697},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4596215784549713},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.45630258321762085},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.41869646310806274},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3520932197570801},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3518161177635193},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3331800401210785},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.1846761405467987},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.09374770522117615},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.08236175775527954},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2018-99-119949","doi":"https://doi.org/10.1182/blood-2018-99-119949","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2018-99-119949","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4289933368","https://openalex.org/W2949766968","https://openalex.org/W2950364027","https://openalex.org/W2585965982","https://openalex.org/W2989259260","https://openalex.org/W2980816621","https://openalex.org/W4389233650","https://openalex.org/W3160538443","https://openalex.org/W2984632606","https://openalex.org/W768647209"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"We":[2],"have":[3],"previously":[4,646],"reported":[5],"initial":[6,448],"high":[7,543,600,611],"response":[8,177,261,544],"rates":[9,92,178,545],"of":[10,45,55,71,95,162,180,190,203,212,228,242,258,260,264,271,286,329,379,410,416,428,430,458,468,477,502,508,535,565,602,616,627,672,747,758,805,870,882,894,905,916,927],"the":[11,29,46,56,68,75,80,91,107,160,188,216,277,353,380,407,447,473,542,598,610,625,689,701,712,723,734,767,778,789,793,813,824,835,846,857],"BRAF":[12,568,606,617],"inhibitor,":[13],"vemurafenib,":[14,364,620],"in":[15,28,79,182,215,233,486,497,514,549,579,638,643],"patients":[16],"(pts)":[17],"with":[18,83,88,103,115,140,148,208,230,240,356,363,385,399,424,546,551,583,587,594,619,645],"relapsed":[19,59,141],"or":[20,420,463,674,749,760,807,872,884,896,907,918,929],"refractory":[21],"(R/R)":[22],"hairy":[23,213,237],"cell":[24,482,493],"leukemia":[25],"(HCL)":[26],"treated":[27],"United":[30],"States":[31],"(Tiacci":[32],"and":[33,53,93,194,206,218,235,262,288,293,307,321,371,391,450,454,490,517,554,571,614,629],"Park":[34],"et":[35],"al.":[36],"N":[37],"Engl":[38],"J":[39],"Med":[40],"2015).":[41],"However,":[42],"follow-up":[43,86,328,475,533],"duration":[44,87,259,427,534],"study":[47],"was":[48,173,199,223,313,346,404,576,591],"short":[49],"(median,":[50],"11.7":[51],"months)":[52],"outcome":[54],"pts":[57,73,114,139,273,280,295,336,355,359,366,382,411,488,550,644],"who":[58],"after":[60,101],"vemurafenib":[61,119,149,181,265,386,398,442,547,575,588,628],"remains":[62],"largely":[63],"unknown.":[64],"Herein,":[65],"we":[66,540,621],"report":[67],"updated":[69],"results":[70],"36":[72,272],"from":[74,153],"completed":[76,281],"clinical":[77,111,693,705,716,727,738,771,782,817,828,839,850,861],"trial":[78,642,694,706,717,728,739,772,783,794,818,829,840,851,862],"U.S.":[81,108],"(NCT01711632)":[82],"a":[84,209,226,326,413,425,505,531,555,635,639],"longer":[85,532],"analysis":[89],"on":[90,166,609,668,743,754,801,866,878,890,901,912,923],"timing":[94],"relapse":[96,339,345,388,566,590],"as":[97,99,185,201,225,249,634],"well":[98],"outcomes":[100],"retreatment":[102,362,403,443],"vemurafenib.":[104],"Methods:":[105],"In":[106],"phase":[109,640],"II":[110,641],"trial,":[112],"adult":[113],"R/R":[116,183,552],"HCL":[117,553,603,648],"received":[118,361,368,375,412],"960mg":[120,157],"bid":[121,155,158,418,422],"monotherapy":[122,548],"for":[123,131,291],"3-6":[124],"months.":[125],"Vemurafenib":[126,402],"dose":[127,415],"reductions":[128],"were":[129,143,247,274,444,460,524,561],"allowed":[130,144],"drug-related":[132,439],"adverse":[133],"events":[134],"(AEs).":[135],"During":[136,472],"subsequent":[137],"follow-up,":[138],"disease":[142],"to":[145,156,174,276,302,344,397,446,537,574,604,688,691,700,703,711,714,722,725,733,736,766,769,777,780,788,791,812,815,823,826,834,837,845,848,856,859],"be":[146],"retreated":[147,384],"at":[150,159,266,282,387,589],"doses":[151],"ranging":[152],"240mg":[154,417],"discretion":[161],"treating":[163],"physician":[164],"based":[165],"prior":[167,506],"tolerability":[168,615],"information.":[169],"The":[170,311,341,436],"primary":[171],"objective":[172],"evaluate":[175],"overall":[176],"(ORR)":[179],"HCL,":[184],"assessed":[186],"by":[187,526],"rate":[189],"complete":[191,250],"remission":[192,196,252],"(CR)":[193],"partial":[195],"(PR).":[197],"CR":[198,319],"defined":[200,224],"normalization":[202,227,241],"any":[204],"organomegaly":[205,234],"cytopenia":[207,229,243],"morphologic":[210],"absence":[211],"cells":[214],"blood":[217],"bone":[219],"marrow":[220],"(BM).":[221],"PR":[222,323],"\u226550%":[231],"reduction":[232],"BM":[236,246],"cells.":[238],"Patients":[239],"without":[244],"confirmatory":[245],"classified":[248],"hematologic":[251],"(CHR).":[253],"Secondary":[254],"objectives":[255],"included":[256,451],"assessment":[257],"efficacy":[263,613],"retreatment.":[267],"Results:":[268],"A":[269],"total":[270],"enrolled":[275],"study;":[278],"32":[279],"least":[283],"4":[284,294,299,365,501],"weeks":[285,300],"treatment":[287,449],"are":[289,622],"evaluable":[290],"response,":[292],"discontinued":[296],"therapy":[297,429,637],"before":[298],"due":[301],"toxicity":[303],"(n=2),":[304],"infection":[305],"(n=1)":[306,516],"patient":[308],"request":[309],"(n=1).":[310,520],"ORR":[312,596],"86%":[314],"(31/36":[315],"pts),":[316],"including":[317],"33%":[318],"(12/36)":[320],"53%":[322],"(19/36).":[324],"With":[325,530],"median":[327,342,426],"24":[330],"months":[331,348,432],"(range,":[332,349,433],"1-64":[333],"months),":[334],"18":[335,354],"(50%)":[337],"experienced":[338],"(Figure).":[340],"time":[343],"19.5":[347],"8.0-45.7":[350],"months).":[351,435],"Among":[352],"relapse,":[357],"13":[358,381],"(72%)":[360],"(22%)":[367],"alternative":[369],"treatments,":[370],"1":[372,392,462,498,581],"pt":[373,393,499,582],"(6%)":[374],"supportive":[376],"care.":[377],"Eleven":[378],"(85%)":[383],"achieved":[389],"PR/CHR":[390],"developed":[394,485,496],"acquired":[395,572],"resistance":[396,573],"KRAS":[400,584],"mutation.":[401,585],"well-tolerated":[405],"but":[406],"majority":[408],"(62%)":[409],"reduce":[414],"(n=5)":[419],"480mg":[421],"(n=3)":[423],"7":[431],"1.5-39":[434],"most":[437],"common":[438],"AEs":[440],"during":[441],"similar":[445],"arthralgia":[452],"(38%)":[453],"rash":[455],"(23%),":[456],"all":[457,478,563],"which":[459],"grade":[461,469],"2,":[464],"except":[465],"one":[466],"case":[467],"3":[470],"rash.":[471],"entire":[474],"period":[476],"pts,":[479],"cutaneous":[480,491],"squamous":[481],"carcinomas":[483],"(SCC)":[484],"5":[487],"(14%)":[489],"basal":[492],"carcinoma":[494],"(BCC)":[495],"(3%),":[500],"whom":[503],"had":[504],"history":[507],"SCC":[509],"(n=1),":[510,512],"BCC":[511],"BCC/melanoma":[513],"situ":[515],"actinic":[518],"keratosis":[519],"All":[521],"these":[522],"cases":[523,564],"managed":[525],"simple":[527],"excision.":[528],"Conclusion:":[529],"up":[536],"64":[538],"months,":[539],"confirm":[541],"favorable":[556],"safety":[557],"profile.":[558],"While":[559],"relapses":[560],"common,":[562],"retained":[567,599],"V600E":[569],"mutation":[570],"rare,":[577],"observed":[578],"only":[580],"Re-treatment":[586],"highly":[592],"effective":[593],"85%":[595],"confirming":[597],"sensitivity":[601],"repeated":[605],"inhibition.":[607],"Based":[608],"anti-tumor":[612],"inhibition":[618],"now":[623],"investigating":[624],"combination":[626],"an":[630,669,744,755,802,867,879,891,902,913,924],"anti-CD20":[631],"antibody,":[632],"obinutuzumab,":[633],"frontline":[636],"untreated":[647],"(NCT03410875).":[649],"Figure.":[650,651],"Disclosures":[652],"Park:":[653],"AstraZeneca:":[654],"Consultancy;":[655,662,664,679,681],"Juno":[656],"Therapeutics:":[657,954],"Consultancy,":[658,666],"Research":[659,937,940,943,955],"Funding;":[660,938,941,944],"Pfizer:":[661,842],"Shire:":[663],"Amgen:":[665],"Membership":[667,742,753,800,865,877,889,900,911,922],"entity's":[670,745,756,803,868,880,892,903,914,925],"Board":[671,746,757,804,869,881,893,904,915,926],"Directors":[673,748,759,806,871,883,895,906,917,928],"advisory":[675,750,761,808,873,885,897,908,919,930],"committees;":[676,751,762,874,886,909,920],"Kite":[677],"Pharma:":[678,797],"Novartis:":[680,752],"Adaptive":[682],"Biotechnologies:":[683],"Consultancy.":[684],"Altman:Bayer:":[685],"Other:":[686,698,709,720,731,764,775,786,810,821,832,843,854,933,946,950],"payment":[687,699,710,721,732,765,811,822,833,844,855],"institution":[690,702,713,724,735,768,779,790,814,825,836,847,858],"conduct":[692,704,715,726,737,770,781,792,816,827,838,849,860],"work;":[695,707,718,729,740,773,784,819,830,841,852,863],"Boeringer":[696],"Ingelheim:":[697],"Epizyme:":[708],"Incyte:":[719],"Cyclacel:":[730],"Syros:":[741],"Ariad:":[763],"Genetech:":[774],"Payment":[776,787],"Agios:":[785],";":[795],"Astellas":[796],"Other;":[798],"Celgene:":[799],"committees,":[809],"FujiFilm:":[820],"Celator:":[831],"GSK:":[853],"BMS:":[864],"Janssen":[875],"Pharmaceuticals:":[876,888],"Immune":[887],"committees.":[898,931],"Rai:Pharmacyclics:":[899],"Roche/Genentech:":[910],"Cellectis:":[921],"Tallman:Daiichi-Sankyo:":[932],"Advisory":[934,947,951],"board;":[935,948,952],"AROG:":[936],"AbbVie:":[939],"Cellerant:":[942],"BioSight:":[945],"Orsenix:":[949],"ADC":[953],"Funding.":[956]},"counts_by_year":[{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-02-21T00:00:00"}